Pathophysiological Subtyping of Abnormalities in Cocaine Dependence - 9
This study has been completed.
New York MDRU
Information provided by:
National Institute on Drug Abuse (NIDA)
First received: April 18, 2001
Last updated: June 23, 2005
Last verified: December 2002
The purpose of this study is to define pathophysiological subtypes of abnormalities in subjects with cocaine dependence.
Behavioral: Cocaine-Related Disorders
||Masking: Open Label
Primary Purpose: Diagnostic
||Pathophysiological Subtyping of Abnormalities in Cocaine Dependence
Primary Outcome Measures:
- Identification of homogenous subgroups within total population of cocaine dependent adults
The objective of this study is to define subgroups of patients with differential treatment outcome on the basis of differential baseline electrophysiological clusters.
|Genders Eligible for Study:
|Accepts Healthy Volunteers:
Cocaine dependence. Seeking residential treatment.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00015275
|New York MDRU
|New York, New York, United States, 10010 |
New York MDRU
||John Rotrosen, M.D.
||New York MDRU
No publications provided
History of Changes
|Other Study ID Numbers:
|Study First Received:
||April 18, 2001
||June 23, 2005
||United States: Federal Government
Additional relevant MeSH terms:
ClinicalTrials.gov processed this record on November 19, 2014
Central Nervous System Agents
Central Nervous System Depressants
Dopamine Uptake Inhibitors
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Uptake Inhibitors
Peripheral Nervous System Agents
Physiological Effects of Drugs
Sensory System Agents